Impact of US Tariffs and Obesity Drug Performance on the Pharmaceutical Industry Emily Field, Head of […] Eli Lilly and Company ( NYSE:LLY ) just reported healthy earnings but the stock price didn't ...

Yahoo Finance Senior Health Reporter Anjalee Khemlani joins Market Domination Co-Hosts Julie Hyman and Josh Lipton to examine what the deal means for the pair of pharmaceutical companies and ...

Review Lilly's (LLY) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock. CVS is fighting to protect its ...

Hims & Hers Health's revenue grew 69% YoY, boosting its outlook. See why HIMS stock’s growth potential and high implied ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Hims & Hers stock tumbled after the company confirmed it would stop selling some compounded weight-loss drugs. Investing.com - Eli Lilly (NYSE:LLY) announced on Tuesday that it would begin selling 7.5 ...

In a recent transaction, Lilly Endowment Inc, a significant shareholder of Eli Lilly & Co (NYSE:LLY), sold a substantial portion of its holdings. According to a Form 4 filing... ByInvesting.com ...

There are no important events for this country at this time. Select "All" to see top events in other countries or view all events.

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

ELI LILLY AND CO (LLY) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 88% based on the firm’s underlying fundamentals and the stock’s ...